Patents by Inventor Katsuo Kamoshita

Katsuo Kamoshita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4464375
    Abstract: 4-Anilinoquinazoline derivatives of formula (I): ##STR1## (in which: R.sup.1 represents a hydrogen atom, a halogen atom, a trifluoromethyl group or a nitro group;R.sup.2 represents a hydrogen atom, a C.sub.1 -C.sub.4 alkyl group, an alkoxy group or a halogen atom; andR.sup.3 represents a hydrogen atom cr a C.sub.1 -C.sub.4 alkyl group)and pharmaceutically acceptable salts thereof are, except where R.sup.1 represents a hydrogen atom or a chlorine atom in the 6- position when R.sup.2 and R.sup.3 both represent hydrogen atoms, new compounds and have been found to possess valuable analgesic and anti-inflammatory activities. These compounds can be prepared by heating the appropriate 4-haloquinazoline with an appropriate aniline or aniline derivative.
    Type: Grant
    Filed: August 3, 1981
    Date of Patent: August 7, 1984
    Assignees: Sankyo Co., Ltd., Ube Industries Ltd.
    Inventors: Shinsaku Kobayashi, Katsuo Kamoshita, Shigeki Nagai, Takeo Honda, Kiroku Oda, Katsutoshi Fujii, Takashi Kobayashi, Mikio Kojima
  • Patent number: 4322420
    Abstract: A method of using 4-anilinoquinazoline derivatives of formula (I): ##STR1## (in which: R.sup.1 represents a hydrogen atom, a halogen, atom, a trifluoromethyl group or a nitro group;R.sup.2 represents a hydrogen atom, a C.sub.1 -C.sub.4 alkyl group, an alkoxy group or a halogen atom; andR.sup.3 represents a hydrogen atom or a C.sub.1 -C.sub.4 alkyl group)and pharmaceutically acceptable salts thereof are, provided that R.sup.1 does not represents a hydrogen atom or a chlorine atom in the 6- position when R.sup.2 and R.sup.3 both represent hydrogen atoms, as an analgesic and anti-inflammatory in the treatment of mammals. These compounds can be prepared by heating the appropriate 4-haloquinazoline with an appropriate aniline or aniline derivative.
    Type: Grant
    Filed: September 11, 1979
    Date of Patent: March 30, 1982
    Assignees: Sankyo Company Limited, UBE Industries
    Inventors: Shinsaku Kobayashi, Katsuo Kamoshita, Shigeki Nagai, Takeo Honda, Kiroku Oda, Katsutoshi Fujii, Takashi Kobayashi, Mikio Kojima
  • Patent number: 3960863
    Abstract: 3-[2-(4-PHENYL-1-PIPERAZINYL)ETHYL]-4H-pyrido[1,2-a]pyrimidin-4-one derivatives have central nervous depressant and hypotensive activities and are useful as major tranquillizers.The compounds can be prepared by (a) reacting 2-methyl-3-halogeno (or arylsulfonyloxy or alkylsulfonyloxy)ethyl-4H-pyrido[1,2-a]pyrimidin-4-one derivative with 1-phenylpiperazine derivative or (b) reacting an aminopyridine with 2-[2-(4-phenyl-1-piperazinyl)ethyl]-acetoacetic acid ester.
    Type: Grant
    Filed: June 5, 1975
    Date of Patent: June 1, 1976
    Assignee: Sankyo Company Limited
    Inventors: Yasunobu Sato, Hiroshi Fujita, Takagi, Katsuo Kamoshita